Clarity Pharmaceuticals Ltd.ASX: CU6

Theranostic prostate cancer trial advances to multi-dose

Mar 15, 2024 at 4:05 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment